Order Article Reprints

Philippe V, Jeannerat A, Peneveyre C, Jaccoud S, Scaletta C, Hirt-Burri N, Abdel-Sayed P, Raffoul W, Darwiche S, Applegate LA, et al. Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification. Pharmaceutics. 2023; 15(9):2333. https://doi.org/10.3390/pharmaceutics15092333

Philippe, Virginie, Annick Jeannerat, Cédric Peneveyre, Sandra Jaccoud, Corinne Scaletta, Nathalie Hirt-Burri, Philippe Abdel-Sayed, Wassim Raffoul, Salim Darwiche, Lee Ann Applegate, and et al. 2023. "Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification" Pharmaceutics 15, no. 9: 2333. https://doi.org/10.3390/pharmaceutics15092333

Philippe, V., Jeannerat, A., Peneveyre, C., Jaccoud, S., Scaletta, C., Hirt-Burri, N., Abdel-Sayed, P., Raffoul, W., Darwiche, S., Applegate, L. A., Martin, R., & Laurent, A. (2023). Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification. Pharmaceutics, 15(9), 2333. https://doi.org/10.3390/pharmaceutics15092333